Ana is a molecular biologist enthusiastic about innovation and communication. In her role as a science writer she wishes to bring the advances in medical science and technology closer to the public, particularly to those most in need of them. Ana holds a PhD in Biomedical Sciences from the University of Lisbon, Portugal, where she focused her research on molecular biology, epigenetics and infectious diseases.
Isturisa (osilodrostat) is now approved in the U.S. for adults with Cushing’s disease for whom pituitary gland surgery is not an option or whose disease has returned after surgery, Recordati ... Read more
While men and women with adrenocorticotropic hormone (ACTH)-dependent Cushing’s syndrome have distinct symptoms and signs, these differences do not justify divergent diagnostic or treatment approaches since both sexes have ... Read more
Data from an ongoing real-world study show that treatment with Signifor (pasireotide) is able to normalize cortisol levels for sustained periods in patients with Cushing’s disease for whom surgery ... Read more
Mifepristone, a synthetic steroid commonly used to taper high blood sugar levels and diminish insulin resistance in patients with Cushing’s syndrome, may also be helpful in managing mild autonomous cortisol secretion ... Read more
Mifepristone, a medicine that blocks glucocorticoid hormone effects, may be useful for preventing adrenal insufficiency in people with Cushing’s syndrome, following surgery to remove adrenal glands, a study using rats ... Read more
Ultrasound scans can be useful to monitor muscle changes in patients with glucocorticoid-induced muscle disease or steroid myopathy, and could become an effective routine procedure for those with Cushing’s disease, ... Read more
Competent physicians and long-term medical care are the types of support that most help patients with Cushing’s syndrome cope with their condition, a patient-reported survey in the U.S. and ... Read more